Press Room http://www.news.sanofi.us/ MediaRoom Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA http://www.news.sanofi.us/Sanofi-and-Regeneron-Announce-Dupilumab-Biologics-License-Application-Accepted-for-Priority-Review-by-U-S-FDA Mon, 26 Sep 2016 06:48:00 -0400 http://www.news.sanofi.us/Sanofi-and-Regeneron-Announce-Dupilumab-Biologics-License-Application-Accepted-for-Priority-Review-by-U-S-FDA Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform http://www.news.sanofi.us/2016-09-12-Sanofi-and-Verily-Life-Sciences-Announce-Launch-of-Onduo-a-Joint-Venture-to-Develop-Comprehensive-Diabetes-Management-Platform - Joshua Riff, M.D., Named Chief Executive Officer - Mon, 12 Sep 2016 08:04:00 -0400 http://www.news.sanofi.us/2016-09-12-Sanofi-and-Verily-Life-Sciences-Announce-Launch-of-Onduo-a-Joint-Venture-to-Develop-Comprehensive-Diabetes-Management-Platform Sanofi Announces Q2 2016 Results http://www.news.sanofi.us/2016-07-29-Sanofi-Announces-Q2-2016-Results Fri, 29 Jul 2016 08:00:00 -0400 http://www.news.sanofi.us/2016-07-29-Sanofi-Announces-Q2-2016-Results Sanofi Receives FDA Approval of Adlyxin™ for Treatment of Adults with Type 2 Diabetes http://www.news.sanofi.us/2016-07-27-Sanofi-Receives-FDA-Approval-of-AdlyxinTM-for-Treatment-of-Adults-with-Type-2-Diabetes - Adlyxin™ is approved as Lyxumia® in more than 60 countries - Wed, 27 Jul 2016 20:12:00 -0400 http://www.news.sanofi.us/2016-07-27-Sanofi-Receives-FDA-Approval-of-AdlyxinTM-for-Treatment-of-Adults-with-Type-2-Diabetes Surveys Find Adults with Type 2 Diabetes Are More Willing to Take Action to Achieve A1C Targets Quicker than Physicians and Other Medical Professionals Perceive http://www.news.sanofi.us/2016-07-20-Surveys-Find-Adults-with-Type-2-Diabetes-Are-More-Willing-to-Take-Action-to-Achieve-A1C-Targets-Quicker-than-Physicians-and-Other-Medical-Professionals-Perceive -- Findings reveal that some patients are frustrated and discontinued medication because they were not reaching their individualized A1C target quick enough -- Wed, 20 Jul 2016 09:05:00 -0400 http://www.news.sanofi.us/2016-07-20-Surveys-Find-Adults-with-Type-2-Diabetes-Are-More-Willing-to-Take-Action-to-Achieve-A1C-Targets-Quicker-than-Physicians-and-Other-Medical-Professionals-Perceive